Hyperfine is collaborating with NVIDIA to advance the AI capabilities of the Swoop Portable magnetic resonance imaging (MRI) ...

On Tuesday, Citi analysts initiated a 90-day downside short-term view on Illumina stock (NASDAQ:ILMN), citing several significant challenges that the company is currently facing. The stock has already ...

Tuesday, Wolfe Research analysts maintained their Outperform rating on Illumina stock (NASDAQ:ILMN), keeping the price target at $150.00 despite recent developments. Currently trading at $88.74, the ...

On Tuesday, Citi analysts initiated a 90-day downside short-term view on Illumina stock (NASDAQ:ILMN), citing several significant challenges that the company is currently facing. The stock has ...

Whether you need to scan family photos, piles of documents, or expense receipts, a scanner out there is built for the task. Here's how to shop for the right one, plus the top performers in our lab ...

SAN DIEGO - Illumina, Inc. (NASDAQ: NASDAQ:ILMN), a $4.37 billion revenue genomics leader with an impressive 68.37% gross margin, today announced a comprehensive suite of new omics technologies, ...

Trade war with China? Check. Cuts to scientific research? Check.

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. The best OBD-II scanners can unlock the secrets of your car, connecting to the onboard ...

Illumina, Inc., a global leader in next-generation sequencing and array-based technologies, announced a collaboration with Broad Clinical Labs to rapidly streamline and scale single-cell projects with ...

At a launch event on Feb. 20, Roche detailed plans to enter Illumina's sequencing stronghold with a new platform. Roche's platform is in testing now and scheduled to launch commercially in 2026.